The resource center contains a warning by the FDA that the procedure of inserting the Mirena IUD can result in perforation of reproductive organs.
New York, NY (PRWEB) May 22, 2013
The prescription device safety advocates at DrugRisks.com are announcing new information on the site for women using the IUD contraceptive Mirena. A special federal court created to handle Mirena lawsuits alleging perforation injuries recently held its first hearing*.
DrugRisks was created to improve the safety of patients using prescription devices like IUDs by providing the latest safety alerts, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide if they need legal advice.
The resource center contains a warning by the FDA that the procedure of inserting the Mirena IUD can result in perforation of reproductive organs**.
DrugRisks has also added a study by the Journal of the Society of Laparoendoscopic Surgeons cautioning patients about the migration and perforation of Mirena IUDs that can occur after the device has been implanted***.
Due to the number of patients filing a Mirena lawsuit alleging perforation injuries, all federal cases were consolidated to a special court in the Southern District of New York (In Re: Mirena IUD Products Liability Litigation, MDL No. 2434). So far, 46 cases have been transferred into the special Mirena MDL****.
Now, DrugRisks has learned that Judge Cathy Seibel, who is presiding over the cases, held the first status conference on May 17th. At that time she suggested that female lawyers hold an active role in the litigation for patients, given the nature of the claims*.
Anyone who suffered perforation or required surgery while using a Mirena IUD is urged to speak with a lawyer about their legal rights. Due to the specialized nature of federal MDL drug injury cases, DrugRisks only recommends lawyers who are already handling Mirena lawsuits.
Visit http://www.DrugRisks.com today for more information on Mirena IUD research, side effects and litigation news, or to speak with a lawyer.
**FDA, July 2008; http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm121936.htm
***JSLS March, 2011; ncbi.nlm.nih.gov/pmc/articles/PMC3134688/
****Judicial Panel on Multidistrict Litigation, 5/15/13; jpml.uscourts.gov/sites/jpml/files/Pending%20MDL%20Dockets_By%20District_May-14-2013.pdf